The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...

Therapeutic vaccines help the immune system seek and destroy cancer cells by targeting specific tumor DNA ...

There were no serious adverse events reported. “Our findings demonstrate that the therapeutic vaccine Vvax001 is safe, well-tolerated, and effective in eradicating HPV16-associated CIN3 lesions ...

David Braun of the Yale Cancer Center in New Haven, Conn. These therapeutic vaccines caused the patients' immune systems to seek and destroy stray cancer cells left over after tumor-removing ...

For patients with HPV16-positive CIN3, vaccination with a replication-incompetent Semliki Forest virus vaccine encoding HPV16 E6 and E7 is safe and shows clinical effectiveness.